Efficacy, Safety, and Pharmacokinetics by Body Mass Index Category in Phase 3/3b Long-Acting Cabotegravir Plus Rilpivirine Trials
The journal of infectious diseases (Online. University of Chicago Press)/The Journal of infectious diseases